Neurocrine Biosciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.49, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Neurocrine Biosciences Inc in Sep 30 2026 quarter, has decreased to 81 days, compared to 83 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 185 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1501, from overall ranking in the second quarter 2026 at 2729.

What is Receivable Turnover Ratio?
What is Neurocrine Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBIX Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	31.5 %	48.9 %	48.86 %	43.35 %	51.32 %
Y / Y Revenue Change	41.24 %	39.49 %	42.25 %	28.33 %	27.78 %
Receivable Turnover Ratio (TTM)	4.49	4.4	4.47	4.53	4.63
NBIX's Total Ranking	# 1501	# 2729	# 1350	# 352	#
Accounts Receivable average collection period days	81	83	82	81	79
Seq. Receivable Change	7.93 %	15.48 %	11.84 %	-5.66 %	22.21 %
Seq. Revenue Change	17.07 %	17.74 %	1.12 %	1.33 %	15.62 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 11
Healthcare Sector	# 186
Overall Market	# 1501

Receivable Turnover Ratio Statistics
High	Average	Low
0.75	0.56	0.02
(Jun 30 2020)		(Dec 31 2013)

NBIX Company Profile • Back to NBIX Efficiency Comparisons • Compare NBIX Receivables Turnover Ratio to its Competitors

Financial Statements
Neurocrine Biosciences Inc 's Accounts Receivable	$ 957 Millions	Visit NBIX's Balance sheet
Neurocrine Biosciences Inc 's Sales TTM	$ 3,702 Millions	Visit NBIX's Income Statement
Sources of NBIX's Revenues		Visit NBIX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NBIX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NBIX's Growth Rates	NBIX's Roa	NBIX's Inventory Turnover Ratio	NBIX's Dividend Comparisons
NBIX's Profitability Ratios	NBIX's Roi	NBIX's Asset Turnover Ratio	NBIX's Dividend Growth
NBIX's Valuation Ratios	NBIX's Roe	NBIX's Financial Strength Ratios	NBIX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions
Aurinia Pharmaceuticals Inc	7.18	$ 321.738 Millions	$ 44.795 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Stryker Corp	6.99	$ 26,300.000 Millions	$ 3,761.500 Millions
Boston Scientific Corporation	6.96	$ 21,070.000 Millions	$ 3,028.750 Millions
Syndax Pharmaceuticals Inc	6.89	$ 289.431 Millions	$ 42.011 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
Iradimed Corporation	6.62	$ 89.340 Millions	$ 13.487 Millions

Date modified: 2026-11-03T10:01:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.